









Markets
/
Stocks
/
nasdaq-brkr
/

Bruker Corp

BRKR

39.000USD

-0.710-1.79%

Close 10/24, 16:00（ET）Quotes delayed by 15 min

5.92BMarket Cap

74.33P/E TTM



Bruker Corp

39.000

-0.710-1.79%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Bruker Corp

Currency: USD Updated: 2025-10-23

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite strong stock market performance and technicals, the fundamentals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Bruker Corp's Score

Industry at a Glance

Industry Ranking

77 / 204

Overall Ranking

195 / 4685

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 15 analysts

Buy

Current Rating

44.612

Target Price

+15.04%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Bruker Corp Highlights

StrengthsRisks

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. Its product lines include nCounter, CosMx, GeoMx and AtoMx. It also owns electron paramagnetic resonance (EPR) business.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 33.02% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 26.70%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 26.70%.

Overvalued

The company’s latest PE is 75.77, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 128.10M shares, decreasing 5.97% quarter-over-quarter.

Held by Joel Greenblatt

Star Investor Joel Greenblatt holds 563.28K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-23

The company's current financial score is 5.47, which is lower than the Healthcare Equipment & Supplies industry's average of 7.47. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 797.40M, representing a year-over-year decrease of 0.41%, while its net profit experienced a year-over-year decrease of 0.00%.

Score

Industry at a Glance

Previous score

5.47

Change



Financials

4.55

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

2.47

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.94

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.13

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

5.26

Key Metrics

Free cash flow

No Data

Bruker Corp's Company Valuation

Currency: USD Updated: 2025-10-23

The company’s current valuation score is 6.80, which is lower than the Healthcare Equipment & Supplies industry's average of 7.16. Its current P/E ratio is 75.77, which is 10.63% below the recent high of 83.82 and 69.46% above the recent low of 23.14.

Score

Industry at a Glance

Previous score

6.80

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 77/204

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-23

The company’s current earnings forecast score is 7.33, which is lower than the Healthcare Equipment & Supplies industry's average of 7.72. The average price target for Bruker Corp is 41.50, with a high of 65.00 and a low of 28.00.

Score

Industry at a Glance

Previous score

7.33

Change

Support & Resistance

No Data

Analyst Rating

Based on 15 analysts

Buy

Current Rating

44.612

Target Price

+12.34%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Bruker Corp

BRKR

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-23

The company’s current price momentum score is 9.31, which is higher than the Healthcare Equipment & Supplies industry's average of 7.16. Sideways: Currently, the stock price is trading between the resistance level at 43.32 and the support level at 33.09, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.19

Change

0.12

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.651

Buy

RSI(14)

62.683

Neutral

STOCH(KDJ)(9,3,3)

72.393

Neutral

ATR(14)

1.883

Low Volatility

CCI(14)

111.787

Buy

Williams %R

29.799

Buy

TRIX(12,20)

0.697

Sell

StochRSI(14)

15.719

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

38.910

Buy

MA10

37.868

Buy

MA20

36.272

Buy

MA50

34.065

Buy

MA100

36.523

Buy

MA200

41.093

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-23

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.37. The latest institutional shareholding proportion is 84.43%, representing a quarter-over-quarter decrease of 25.44%. The largest institutional shareholder is The Vanguard, holding a total of 10.40M shares, representing 6.86% of shares outstanding, with 2.18% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Laukien (Frank H)

40.41M

+0.08%

T. Rowe Price Investment Management, Inc.

11.43M

-7.69%

The Vanguard Group, Inc.

Star Investors

10.40M

-1.17%

Pallas Capital Advisors LLC

9.50M

+0.06%

BlackRock Institutional Trust Company, N.A.

9.40M

-7.88%

Laukien (Joerg C)

7.52M

Fidelity Management & Research Company LLC

7.47M

-23.89%

Orbis Investment Management Ltd.

4.68M

The London Company of Virginia, LLC

4.02M

-2.78%

State Street Investment Management (US)

3.78M

-1.12%

Risk Assessment

Currency: USD Updated: 2025-10-23

The company’s current risk assessment score is 4.79, which is higher than the Healthcare Equipment & Supplies industry's average of 4.64. The company's beta value is 1.23. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.